We further revealed inhibited liver cancer cell migration and invasion through suppressed cofilin activity, as well as downregulation of the AKT/NF-κB signaling pathway resulted in a decrease MMP-2/MMP-9 expression by PP2 treatment. The gene discussed is MMP9; the disease is liver cancer.